CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Celator Pharmaceuticals is a pharmaceutical company developing new and effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents an approach that identifies molar ratios of drugs that will deliver a syne...Show all
Company (Acquired)
Phone: 609-243-0123
303B College Road East
Princeton, 08540
New Jersey, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Celator Pharmaceuticals | $156.3M | Jul 13, 2016 |
| Cequent Pharmaceuticals | $16.9M | Apr 1, 2010 |
| Novacea | $100.8M | May 10, 2006 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Assays and methods for selecting a treatment regimen for a subject with leukemia | Nov 10, 2016 | Feb 23, 2021 | Patent |
| Particulate constructs for release of active agents | May 29, 2013 | Feb 02, 2021 | Patent |
| Method of lyophilizing liposomes | Nov 05, 2018 | Nov 17, 2020 | Patent |
| Compositions for delivery of drug combinations | Jul 27, 2018 | Jul 28, 2020 | Patent |
| Improved nanoparticle delivery systems | Jul 14, 2016 | May 14, 2019 | Patent |
